Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > The more you guys try to silence me

<< Previous

Bullboard Posts

Next >>

Comment by threefiftynineon Jun 29, 2020 2:48pm

87 Views

Post# 31204358

RE:The more you guys try to silence me

"DIG DEEP"---The only way to do that is to contact IROC----find out why a rep. for the broker sends emails to pop dik and harry giving out info that is pasted on to a public board------YA!---This is getting more embarrassing as the days go bye for a company testing for a vaccine that can save the planet--------frikkin amatuer

<< Previous

Bullboard Posts

Next >>

Record Q3: Equinox Gold achieves commercial production at Greenstone Mine